AU6853900A - Method for coupling molecules - Google Patents

Method for coupling molecules Download PDF

Info

Publication number
AU6853900A
AU6853900A AU68539/00A AU6853900A AU6853900A AU 6853900 A AU6853900 A AU 6853900A AU 68539/00 A AU68539/00 A AU 68539/00A AU 6853900 A AU6853900 A AU 6853900A AU 6853900 A AU6853900 A AU 6853900A
Authority
AU
Australia
Prior art keywords
chemical compound
group
compound according
formula
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68539/00A
Other languages
English (en)
Inventor
Michael John Gait
Dmitry Stetsenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9920397.8A external-priority patent/GB9920397D0/en
Priority claimed from GB0012083A external-priority patent/GB0012083D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU6853900A publication Critical patent/AU6853900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU68539/00A 1999-08-27 2000-08-25 Method for coupling molecules Abandoned AU6853900A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9920397.8A GB9920397D0 (en) 1999-08-27 1999-08-27 Method for coupling molecules
GB9920397 1999-08-27
GB0012083 2000-05-18
GB0012083A GB0012083D0 (en) 2000-05-18 2000-05-18 Method for coupling molecules
PCT/GB2000/003306 WO2001015737A2 (en) 1999-08-27 2000-08-25 Method for coupling molecules

Publications (1)

Publication Number Publication Date
AU6853900A true AU6853900A (en) 2001-03-26

Family

ID=26244310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68539/00A Abandoned AU6853900A (en) 1999-08-27 2000-08-25 Method for coupling molecules

Country Status (5)

Country Link
EP (1) EP1207909A2 (de)
JP (1) JP2003508450A (de)
AU (1) AU6853900A (de)
CA (1) CA2382499A1 (de)
WO (1) WO2001015737A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569392B2 (en) 2004-01-08 2009-08-04 Vanderbilt University Multiplex spatial profiling of gene expression
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
RU2708237C2 (ru) 2014-08-22 2019-12-05 Общество с ограниченной ответственностью "НооГен" Модифицированные олигонуклеотиды и способ их получения
JP7194635B2 (ja) * 2019-04-25 2022-12-22 あおみ建設株式会社 隙間の充填工法

Also Published As

Publication number Publication date
CA2382499A1 (en) 2001-03-08
JP2003508450A (ja) 2003-03-04
WO2001015737A3 (en) 2001-11-15
EP1207909A2 (de) 2002-05-29
WO2001015737A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
WO2019035971A1 (en) 6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS TOLL 7 RECEPTOR IMMUNOSTIMULATING AGONISTS (TLR7)
WO2019209811A1 (en) Macrocyclic toll-like receptor 7 (tlr7) agonists
JPH06506945A (ja) ペプチド核酸
CN1312817A (zh) 截尾海兔肽15衍生物
WO2005076744A2 (en) Method for the preparation of peptide-oligonucleotide conjugates
JPH07285989A (ja) 弱酸に不安定であるアミノ保護基を使用するｐｎａの合成
CN110974975B (zh) 一种快速释放的抗体药物偶联物
CA2528667C (en) Reagents for modifying biopharmaceuticals, the use and production thereof
Brown et al. Conjugation of an oligonucleotide to Tat, a cell-penetrating peptide, via click chemistry
AU2010248206A1 (en) Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
US20120035362A1 (en) Phosphoramidite derivatives of folic acid
AU2022287635A1 (en) DisuIfide bond containing compounds and uses thereof
AU6853900A (en) Method for coupling molecules
US20050208015A1 (en) Glycerol derivative
Aldrian‐Herrada et al. Solid‐phase synthesis of peptide nucleic acid (PNA) monomers and their oligomerization using disulphide anchoring linkers
KR100241948B1 (ko) N알파-2-(4-나이트로페닐설포닐)에톡시카르보닐-아미노산류
FI88031C (fi) 4-(substituerad aminokarbonyloximetyl)fenoxiaettiksyraderivat, foerfarande foer framstaellning av dessa och deras anvaendning i en fastfassyntes av peptid-aminoalkylamider
Oakley et al. Synthesis of a hybrid protein containing the iron-binding ligand of bleomycin and the DNA-binding domain of Hin
WO2015173665A1 (en) A process for preparation of trans-sulfuric acid mono-{2-[5-(3-azetidinylamino)-methyl-[1,3,4]- oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo[3.2.1] oct-6-yl} ester trifluoroacetate
de Koning et al. Synthesis of a PNA-peptide conjugate by chemical ligation
Matthews et al. Monofunctional electrophilic and nucleophilic derivatives of meso-tetraphenylporphyrin for attachment to peptides
CA2408885A1 (en) Vectors for dna delivery
US20060058218A1 (en) Solid phase conjugation of complexing agents and targeting moieties
US20230313180A1 (en) Multimeric antibody platform and methods of making and using multimeric antibody platform
ES2403129B1 (es) Compuestos maleimido-furanilo útiles en un procedimiento general de preparación de derivados maleimido-oligonucleótido